1 Study Coverage 1.1 Oxaliplatin Injection Product Introduction 1.2 Market by Type 1.2.1 Global Oxaliplatin Injection Market Size Growth Rate by Type 1.2.2 Mannitol 1.2.3 Glucose Solution 1.2.4 Lactose Solution 1.2.5 Other 1.3 Market by Application 1.3.1 Global Oxaliplatin Injection Market Size Growth Rate by Application 1.3.2 Colorectal Cancer 1.3.3 Stomach Cancer 1.3.4 Ovarian Cancer 1.3.5 Other 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Oxaliplatin Injection Market Size, Estimates and Forecasts 2.1.1 Global Oxaliplatin Injection Revenue 2016-2027 2.1.2 Global Oxaliplatin Injection Sales 2016-2027 2.2 Global Oxaliplatin Injection, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Oxaliplatin Injection Historical Market Size by Region (2016-2021) 2.3.1 Global Oxaliplatin Injection Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Oxaliplatin Injection Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Oxaliplatin Injection Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Oxaliplatin Injection Sales Forecast by Region (2022-2027) 2.4.2 Global Oxaliplatin Injection Revenue Forecast by Region (2022-2027) 3 Global Oxaliplatin Injection Competitor Landscape by Players 3.1 Global Top Oxaliplatin Injection Manufacturers by Sales 3.1.1 Global Oxaliplatin Injection Sales by Manufacturer (2016-2021) 3.1.2 Global Oxaliplatin Injection Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Oxaliplatin Injection Manufacturers by Revenue 3.2.1 Key Oxaliplatin Injection Manufacturers Covered: Ranking by Revenue 3.2.2 Global Oxaliplatin Injection Revenue by Manufacturers (2016-2021) 3.2.3 Global Oxaliplatin Injection Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Oxaliplatin Injection Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Oxaliplatin Injection Revenue in 2020 3.2.6 Global Oxaliplatin Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Oxaliplatin Injection Price by Manufacturers 3.4 Global Oxaliplatin Injection Manufacturing Base Distribution, Product Types 3.4.1 Oxaliplatin Injection Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Oxaliplatin Injection Product Type 3.4.3 Date of International Manufacturers Enter into Oxaliplatin Injection Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Oxaliplatin Injection Market Size by Type (2016-2021) 4.1.1 Global Oxaliplatin Injection Sales by Type (2016-2021) 4.1.2 Global Oxaliplatin Injection Revenue by Type (2016-2021) 4.1.3 Oxaliplatin Injection Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Oxaliplatin Injection Market Size Forecast by Type (2022-2027) 4.2.1 Global Oxaliplatin Injection Sales Forecast by Type (2022-2027) 4.2.2 Global Oxaliplatin Injection Revenue Forecast by Type (2022-2027) 4.2.3 Oxaliplatin Injection Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Oxaliplatin Injection Market Size by Application (2016-2021) 5.1.1 Global Oxaliplatin Injection Sales by Application (2016-2021) 5.1.2 Global Oxaliplatin Injection Revenue by Application (2016-2021) 5.1.3 Oxaliplatin Injection Price by Application (2016-2021) 5.2 Oxaliplatin Injection Market Size Forecast by Application (2022-2027) 5.2.1 Global Oxaliplatin Injection Sales Forecast by Application (2022-2027) 5.2.2 Global Oxaliplatin Injection Revenue Forecast by Application (2022-2027) 5.2.3 Global Oxaliplatin Injection Price Forecast by Application (2022-2027) 6 China by Players, Type and Application 6.1 China Oxaliplatin Injection Market Size YoY Growth 2016-2027 6.1.1 China Oxaliplatin Injection Sales YoY Growth 2016-2027 6.1.2 China Oxaliplatin Injection Revenue YoY Growth 2016-2027 6.1.3 China Oxaliplatin Injection Market Share in Global Market 2016-2027 6.2 China Oxaliplatin Injection Market Size by Players (International and Local Players) 6.2.1 China Top Oxaliplatin Injection Players by Sales (2016-2021) 6.2.2 China Top Oxaliplatin Injection Players by Revenue (2016-2021) 6.3 China Oxaliplatin Injection Historic Market Review by Type (2016-2021) 6.3.1 China Oxaliplatin Injection Sales Market Share by Type (2016-2021) 6.3.2 China Oxaliplatin Injection Revenue Market Share by Type (2016-2021) 6.3.3 China Oxaliplatin Injection Price by Type (2016-2021) 6.4 China Oxaliplatin Injection Market Estimates and Forecasts by Type (2022-2027) 6.4.1 China Oxaliplatin Injection Sales Forecast by Type (2022-2027) 6.4.2 China Oxaliplatin Injection Revenue Forecast by Type (2022-2027) 6.4.3 China Oxaliplatin Injection Price Forecast by Type (2022-2027) 6.5 China Oxaliplatin Injection Historic Market Review by Application (2016-2021) 6.5.1 China Oxaliplatin Injection Sales Market Share by Application (2016-2021) 6.5.2 China Oxaliplatin Injection Revenue Market Share by Application (2016-2021) 6.5.3 China Oxaliplatin Injection Price by Application (2016-2021) 6.6 China Oxaliplatin Injection Market Estimates and Forecasts by Application (2022-2027) 6.6.1 China Oxaliplatin Injection Sales Forecast by Application (2022-2027) 6.6.2 China Oxaliplatin Injection Revenue Forecast by Application (2022-2027) 6.6.3 China Oxaliplatin Injection Price Forecast by Application (2022-2027) 7 North America 7.1 North America Oxaliplatin Injection Market Size YoY Growth 2016-2027 7.2 North America Oxaliplatin Injection Market Facts & Figures by Country 7.2.1 North America Oxaliplatin Injection Sales by Country (2016-2021) 7.2.2 North America Oxaliplatin Injection Revenue by Country (2016-2021) 7.2.3 United States 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Oxaliplatin Injection Market Size YoY Growth 2016-2027 8.2 Asia Pacific Oxaliplatin Injection Market Facts & Figures by Region 8.2.1 Asia Pacific Oxaliplatin Injection Sales by Region (2016-2021) 8.2.2 Asia Pacific Oxaliplatin Injection Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 9 Europe 9.1 Europe Oxaliplatin Injection Market Size YoY Growth 2016-2027 9.2 Europe Oxaliplatin Injection Market Facts & Figures by Country 9.2.1 Europe Oxaliplatin Injection Sales by Country (2016-2021) 9.2.2 Europe Oxaliplatin Injection Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Oxaliplatin Injection Market Size YoY Growth 2016-2027 10.2 Latin America Oxaliplatin Injection Market Facts & Figures by Country 10.2.1 Latin America Oxaliplatin Injection Sales by Country (2016-2021) 10.2.2 Latin America Oxaliplatin Injection Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Oxaliplatin Injection Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Oxaliplatin Injection Market Facts & Figures by Country 11.2.1 Middle East and Africa Oxaliplatin Injection Sales by Country (2016-2021) 11.2.2 Middle East and Africa Oxaliplatin Injection Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 Sanofi-Aventis 12.1.1 Sanofi-Aventis Corporation Information 12.1.2 Sanofi-Aventis Description and Business Overview 12.1.3 Sanofi-Aventis Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Sanofi-Aventis Oxaliplatin Injection Products Offered 12.1.5 Sanofi-Aventis Recent Development 12.2 Yakult honsha 12.2.1 Yakult honsha Corporation Information 12.2.2 Yakult honsha Description and Business Overview 12.2.3 Yakult honsha Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Yakult honsha Oxaliplatin Injection Products Offered 12.2.5 Yakult honsha Recent Development 12.3 Dr Reddy's laboratories 12.3.1 Dr Reddy's laboratories Corporation Information 12.3.2 Dr Reddy's laboratories Description and Business Overview 12.3.3 Dr Reddy's laboratories Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Dr Reddy's laboratories Oxaliplatin Injection Products Offered 12.3.5 Dr Reddy's laboratories Recent Development 12.4 Sun Pharmaceutical 12.4.1 Sun Pharmaceutical Corporation Information 12.4.2 Sun Pharmaceutical Description and Business Overview 12.4.3 Sun Pharmaceutical Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Sun Pharmaceutical Oxaliplatin Injection Products Offered 12.4.5 Sun Pharmaceutical Recent Development 12.5 Teva 12.5.1 Teva Corporation Information 12.5.2 Teva Description and Business Overview 12.5.3 Teva Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Teva Oxaliplatin Injection Products Offered 12.5.5 Teva Recent Development 12.6 Fresenius Kabi 12.6.1 Fresenius Kabi Corporation Information 12.6.2 Fresenius Kabi Description and Business Overview 12.6.3 Fresenius Kabi Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Fresenius Kabi Oxaliplatin Injection Products Offered 12.6.5 Fresenius Kabi Recent Development 12.7 Hospira(Pfizer) 12.7.1 Hospira(Pfizer) Corporation Information 12.7.2 Hospira(Pfizer) Description and Business Overview 12.7.3 Hospira(Pfizer) Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Hospira(Pfizer) Oxaliplatin Injection Products Offered 12.7.5 Hospira(Pfizer) Recent Development 12.8 Mylan 12.8.1 Mylan Corporation Information 12.8.2 Mylan Description and Business Overview 12.8.3 Mylan Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Mylan Oxaliplatin Injection Products Offered 12.8.5 Mylan Recent Development 12.9 Jiangsu Hengrui Medicine 12.9.1 Jiangsu Hengrui Medicine Corporation Information 12.9.2 Jiangsu Hengrui Medicine Description and Business Overview 12.9.3 Jiangsu Hengrui Medicine Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Jiangsu Hengrui Medicine Oxaliplatin Injection Products Offered 12.9.5 Jiangsu Hengrui Medicine Recent Development 12.10 Nanjing Pharmaceutical Factory 12.10.1 Nanjing Pharmaceutical Factory Corporation Information 12.10.2 Nanjing Pharmaceutical Factory Description and Business Overview 12.10.3 Nanjing Pharmaceutical Factory Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Nanjing Pharmaceutical Factory Oxaliplatin Injection Products Offered 12.10.5 Nanjing Pharmaceutical Factory Recent Development 12.11 Sanofi-Aventis 12.11.1 Sanofi-Aventis Corporation Information 12.11.2 Sanofi-Aventis Description and Business Overview 12.11.3 Sanofi-Aventis Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Sanofi-Aventis Oxaliplatin Injection Products Offered 12.11.5 Sanofi-Aventis Recent Development 12.12 Qilu Pharmaceutical 12.12.1 Qilu Pharmaceutical Corporation Information 12.12.2 Qilu Pharmaceutical Description and Business Overview 12.12.3 Qilu Pharmaceutical Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Qilu Pharmaceutical Products Offered 12.12.5 Qilu Pharmaceutical Recent Development 12.13 Hisun Pharmaceutical 12.13.1 Hisun Pharmaceutical Corporation Information 12.13.2 Hisun Pharmaceutical Description and Business Overview 12.13.3 Hisun Pharmaceutical Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Hisun Pharmaceutical Products Offered 12.13.5 Hisun Pharmaceutical Recent Development 12.14 Lunan Pharmaceutical 12.14.1 Lunan Pharmaceutical Corporation Information 12.14.2 Lunan Pharmaceutical Description and Business Overview 12.14.3 Lunan Pharmaceutical Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021) 12.14.4 Lunan Pharmaceutical Products Offered 12.14.5 Lunan Pharmaceutical Recent Development 12.15 Luoxin 12.15.1 Luoxin Corporation Information 12.15.2 Luoxin Description and Business Overview 12.15.3 Luoxin Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021) 12.15.4 Luoxin Products Offered 12.15.5 Luoxin Recent Development 12.16 Halfsky Pharmacy 12.16.1 Halfsky Pharmacy Corporation Information 12.16.2 Halfsky Pharmacy Description and Business Overview 12.16.3 Halfsky Pharmacy Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021) 12.16.4 Halfsky Pharmacy Products Offered 12.16.5 Halfsky Pharmacy Recent Development 12.17 YRPG 12.17.1 YRPG Corporation Information 12.17.2 YRPG Description and Business Overview 12.17.3 YRPG Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021) 12.17.4 YRPG Products Offered 12.17.5 YRPG Recent Development 12.18 Hainan Jinrui Pharmaceutical 12.18.1 Hainan Jinrui Pharmaceutical Corporation Information 12.18.2 Hainan Jinrui Pharmaceutical Description and Business Overview 12.18.3 Hainan Jinrui Pharmaceutical Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021) 12.18.4 Hainan Jinrui Pharmaceutical Products Offered 12.18.5 Hainan Jinrui Pharmaceutical Recent Development 12.19 Jari Pharmaceutical 12.19.1 Jari Pharmaceutical Corporation Information 12.19.2 Jari Pharmaceutical Description and Business Overview 12.19.3 Jari Pharmaceutical Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021) 12.19.4 Jari Pharmaceutical Products Offered 12.19.5 Jari Pharmaceutical Recent Development 12.20 Chiatai Tianqing 12.20.1 Chiatai Tianqing Corporation Information 12.20.2 Chiatai Tianqing Description and Business Overview 12.20.3 Chiatai Tianqing Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021) 12.20.4 Chiatai Tianqing Products Offered 12.20.5 Chiatai Tianqing Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Oxaliplatin Injection Industry Trends 13.2 Oxaliplatin Injection Market Drivers 13.3 Oxaliplatin Injection Market Challenges 13.4 Oxaliplatin Injection Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Oxaliplatin Injection Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Oxaliplatin Injection Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Mannitol Table 3. Major Manufacturers of Glucose Solution Table 4. Major Manufacturers of Lactose Solution Table 5. Major Manufacturers of Other Table 6. Global Oxaliplatin Injection Market Size Growth Rate by Application (2021-2027) & (K Units) Table 7. Global Oxaliplatin Injection Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027 Table 8. Global Oxaliplatin Injection Sales by Regions (2016-2021) & (K Units) Table 9. Global Oxaliplatin Injection Sales Market Share by Regions (2016-2021) Table 10. Global Oxaliplatin Injection Revenue by Regions (2016-2021) & (US$ Million) Table 11. Global Oxaliplatin Injection Sales Forecast by Region (2022-2027) & (K Units) Table 12. Global Oxaliplatin Injection Sales Market Share Forecast by Region (2022-2027) Table 13. Global Oxaliplatin Injection Revenue Forecast by Region (2022-2027) & (US$ Million) Table 14. Global Oxaliplatin Injection Revenue Market Share Forecast by Region (2022-2027) Table 15. Global Oxaliplatin Injection Sales by Manufacturers (2016-2021) (K Units) Table 16. Global Oxaliplatin Injection Sales Share by Manufacturers (2016-2021) Table 17. Ranking of Global Top Oxaliplatin Injection Manufacturers by Revenue (US$ Million) in 2020 Table 18. Oxaliplatin Injection Revenue by Manufacturers (2016-2021) (US$ Million) Table 19. Oxaliplatin Injection Revenue Share by Manufacturers (2016-2021) Table 20. Global Oxaliplatin Injection Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 21. Global Oxaliplatin Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oxaliplatin Injection as of 2020) Table 22. Key Manufacturers Oxaliplatin Injection Price (2016-2021) (US$/Unit) Table 23. Oxaliplatin Injection Manufacturers Manufacturing Base Distribution and Headquarters Table 24. Manufacturers Oxaliplatin Injection Product Type Table 25. Date of International Manufacturers Enter into Oxaliplatin Injection Market Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans Table 27. Global Oxaliplatin Injection Sales by Type (2016-2021) (K Units) Table 28. Global Oxaliplatin Injection Sales Share by Type (2016-2021) Table 29. Global Oxaliplatin Injection Revenue by Type (2016-2021) (US$ Million) Table 30. Global Oxaliplatin Injection Revenue Share by Type (2016-2021) Table 31. Oxaliplatin Injection Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit) Table 32. Global Oxaliplatin Injection Sales Forecast by Type (2022-2027) & (K Units) Table 33. Global Oxaliplatin Injection Sales Market Share Forecast by Type (2022-2027) Table 34. Global Oxaliplatin Injection Revenue Forecast V (2022-2027) & (US$ Million) Table 35. Global Oxaliplatin Injection Revenue Market Share Forecast by Type (2022-2027) Table 36. Global Oxaliplatin Injection Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit) Table 37. Global Oxaliplatin Injection Sales by Application (2016-2021) (K Units) Table 38. Global Oxaliplatin Injection Sales Share by Application (2016-2021) Table 39. Global Oxaliplatin Injection Revenue by Application (2016-2021) (US$ Million) Table 40. Global Oxaliplatin Injection Revenue Share by Application (2016-2021) Table 41. Oxaliplatin Injection Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit) Table 42. Global Oxaliplatin Injection Sales Forecast by Application (2022-2027) & (K Units) Table 43. Global Oxaliplatin Injection Sales Market Share Forecast by Application (2022-2027) Table 44. Global Oxaliplatin Injection Revenue Forecast by Application (2022-2027) & (US$ Million) Table 45. Global Oxaliplatin Injection Revenue Market Share Forecast by Application (2022-2027) Table 46. Global Oxaliplatin Injection Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit) Table 47. China Oxaliplatin Injection Sales (K Units) of Key Companies (2016-2021) Table 48. China Oxaliplatin Injection Sales Share by Company (2016-2021) Table 49. China Oxaliplatin Injection Revenue (US$ Million) by Company (2016-2021) Table 50. China Oxaliplatin Injection Revenue Share by Company (2016-2021) Table 51. China Oxaliplatin Injection Sales (K Units) by Type (2016-2021) Table 52. China Oxaliplatin Injection Sales Share by Type (2016-2021) Table 53. China Oxaliplatin Injection Revenue (US$ Million) Market Share by Type (2016-2021) Table 54. China Oxaliplatin Injection Price (US$/Unit) by Type (2016-2021) Table 55. China Oxaliplatin Injection Sales (K Units) by Type (2022-2027) Table 56. China Oxaliplatin Injection Sales Share by Type (2022-2027) Table 57. China Oxaliplatin Injection Revenue (US$ Million) Market Share by Type (2022-2027) Table 58. China Oxaliplatin Injection Revenue Share by Type (2022-2027) Table 59. China Oxaliplatin Injection Price (US$/Unit) by Type (2022-2027) Table 60. China Oxaliplatin Injection Sales (K Units) by Application (2016-2021) Table 61. China Oxaliplatin Injection Sales Share by Application (2016-2021) Table 62. China Oxaliplatin Injection Revenue (US$ Million) Market Share by Application (2016-2021) Table 63. China Oxaliplatin Injection Price (US$/Unit) by Application (2016-2021) Table 64. China Oxaliplatin Injection Sales (K Units) by Application (2022-2027) Table 65. China Oxaliplatin Injection Sales Share by Application (2022-2027) Table 66. China Oxaliplatin Injection Revenue (US$ Million) Market Share by Application (2022-2027) Table 67. China Oxaliplatin Injection Revenue Share by Application (2022-2027) Table 68. China Oxaliplatin Injection Price (US$/Unit) by Application (2022-2027) Table 69. North America Oxaliplatin Injection Sales by Country (2016-2021) & (K Units) Table 70. North America Oxaliplatin Injection Sales Market Share by Country (2016-2021) Table 71. North America Oxaliplatin Injection Revenue by Country (2016-2021) & (US$ Million) Table 72. North America Oxaliplatin Injection Revenue Market Share by Country (2016-2021) Table 73. Asia Pacific Oxaliplatin Injection Sales by Region (2016-2021) & (K Units) Table 74. Asia Pacific Oxaliplatin Injection Sales Market Share by Region (2016-2021) Table 75. Asia Pacific Oxaliplatin Injection Revenue by Region (2016-2021) & (US$ Million) Table 76. Asia Pacific Oxaliplatin Injection Revenue Market Share by Region (2016-2021) Table 77. Europe Oxaliplatin Injection Sales by Country (2016-2021) & (K Units) Table 78. Europe Oxaliplatin Injection Sales Market Share by Country (2016-2021) Table 79. Europe Oxaliplatin Injection Revenue by Country (2016-2021) & (US$ Million) Table 80. Europe Oxaliplatin Injection Revenue Market Share by Country (2016-2021) Table 81. Latin America Oxaliplatin Injection Sales by Country (2016-2021) & (K Units) Table 82. Latin America Oxaliplatin Injection Sales Market Share by Country (2016-2021) Table 83. Latin Americaa Oxaliplatin Injection Revenue by Country (2016-2021) & (US$ Million) Table 84. Latin America Oxaliplatin Injection Revenue Market Share by Country (2016-2021) Table 85. Middle East and Africa Oxaliplatin Injection Sales by Country (2016-2021) & (K Units) Table 86. Middle East and Africa Oxaliplatin Injection Sales Market Share by Country (2016-2021) Table 87. Middle East and Africa Oxaliplatin Injection Revenue by Country (2016-2021) & (US$ Million) Table 88. Middle East and Africa Oxaliplatin Injection Revenue Market Share by Country (2016-2021) Table 89. Sanofi-Aventis Corporation Information Table 90. Sanofi-Aventis Description and Business Overview Table 91. Sanofi-Aventis Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 92. Sanofi-Aventis Oxaliplatin Injection Product Table 93. Sanofi-Aventis Recent Development Table 94. Yakult honsha Corporation Information Table 95. Yakult honsha Description and Business Overview Table 96. Yakult honsha Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 97. Yakult honsha Product Table 98. Yakult honsha Recent Development Table 99. Dr Reddy's laboratories Corporation Information Table 100. Dr Reddy's laboratories Description and Business Overview Table 101. Dr Reddy's laboratories Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 102. Dr Reddy's laboratories Product Table 103. Dr Reddy's laboratories Recent Development Table 104. Sun Pharmaceutical Corporation Information Table 105. Sun Pharmaceutical Description and Business Overview Table 106. Sun Pharmaceutical Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 107. Sun Pharmaceutical Product Table 108. Sun Pharmaceutical Recent Development Table 109. Teva Corporation Information Table 110. Teva Description and Business Overview Table 111. Teva Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 112. Teva Product Table 113. Teva Recent Development Table 114. Fresenius Kabi Corporation Information Table 115. Fresenius Kabi Description and Business Overview Table 116. Fresenius Kabi Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 117. Fresenius Kabi Product Table 118. Fresenius Kabi Recent Development Table 119. Hospira(Pfizer) Corporation Information Table 120. Hospira(Pfizer) Description and Business Overview Table 121. Hospira(Pfizer) Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 122. Hospira(Pfizer) Product Table 123. Hospira(Pfizer) Recent Development Table 124. Mylan Corporation Information Table 125. Mylan Description and Business Overview Table 126. Mylan Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 127. Mylan Product Table 128. Mylan Recent Development Table 129. Jiangsu Hengrui Medicine Corporation Information Table 130. Jiangsu Hengrui Medicine Description and Business Overview Table 131. Jiangsu Hengrui Medicine Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 132. Jiangsu Hengrui Medicine Product Table 133. Jiangsu Hengrui Medicine Recent Development Table 134. Nanjing Pharmaceutical Factory Corporation Information Table 135. Nanjing Pharmaceutical Factory Description and Business Overview Table 136. Nanjing Pharmaceutical Factory Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 137. Nanjing Pharmaceutical Factory Product Table 138. Nanjing Pharmaceutical Factory Recent Development Table 139. Jiangsu Aosaikang Pharmaceutical Corporation Information Table 140. Jiangsu Aosaikang Pharmaceutical Description and Business Overview Table 141. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 142. Jiangsu Aosaikang Pharmaceutical Product Table 143. Jiangsu Aosaikang Pharmaceutical Recent Development Table 144. Qilu Pharmaceutical Corporation Information Table 145. Qilu Pharmaceutical Description and Business Overview Table 146. Qilu Pharmaceutical Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 147. Qilu Pharmaceutical Product Table 148. Qilu Pharmaceutical Recent Development Table 149. Hisun Pharmaceutical Corporation Information Table 150. Hisun Pharmaceutical Description and Business Overview Table 151. Hisun Pharmaceutical Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 152. Hisun Pharmaceutical Product Table 153. Hisun Pharmaceutical Recent Development Table 154. Lunan Pharmaceutical Corporation Information Table 155. Lunan Pharmaceutical Description and Business Overview Table 156. Lunan Pharmaceutical Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 157. Lunan Pharmaceutical Product Table 158. Lunan Pharmaceutical Recent Development Table 159. Luoxin Corporation Information Table 160. Luoxin Description and Business Overview Table 161. Luoxin Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 162. Luoxin Product Table 163. Luoxin Recent Development Table 164. Halfsky Pharmacy Corporation Information Table 165. Halfsky Pharmacy Description and Business Overview Table 166. Halfsky Pharmacy Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 167. Halfsky Pharmacy Product Table 168. Halfsky Pharmacy Recent Development Table 169. YRPG Corporation Information Table 170. YRPG Description and Business Overview Table 171. YRPG Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 172. YRPG Product Table 173. YRPG Recent Development Table 174. Hainan Jinrui Pharmaceutical Corporation Information Table 175. Hainan Jinrui Pharmaceutical Description and Business Overview Table 176. Hainan Jinrui Pharmaceutical Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 177. Hainan Jinrui Pharmaceutical Product Table 178. Hainan Jinrui Pharmaceutical Recent Development Table 179. Jari Pharmaceutical Corporation Information Table 180. Jari Pharmaceutical Description and Business Overview Table 181. Jari Pharmaceutical Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 182. Jari Pharmaceutical Product Table 183. Jari Pharmaceutical Recent Development Table 184. Chiatai Tianqing Corporation Information Table 185. Chiatai Tianqing Description and Business Overview Table 186. Chiatai Tianqing Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 187. Chiatai Tianqing Product Table 188. Chiatai Tianqing Recent Development Table 189. Oxaliplatin Injection Market Trends Table 190. Oxaliplatin Injection Market Drivers Table 191. Oxaliplatin Injection Market Challenges Table 192. Oxaliplatin Injection Market Restraints Table 193. Oxaliplatin Injection Customers List Table 194. Oxaliplatin Injection Distributors List Table 195. Research Programs/Design for This Report Table 196. Key Data Information from Secondary Sources Table 197. Key Data Information from Primary Sources List of Figures Figure 1. Oxaliplatin Injection Product Picture Figure 2. Global Oxaliplatin Injection Sales Market Share by Type in 2020 & 2027 Figure 3. Mannitol Product Picture Figure 4. Glucose Solution Product Picture Figure 5. Lactose Solution Product Picture Figure 6. Other Product Picture Figure 7. Global Oxaliplatin Injection Sales Market Share by Application in 2020 & 2027 Figure 8. Colorectal Cancer Figure 9. Stomach Cancer Figure 10. Ovarian Cancer Figure 11. Other Figure 12. Oxaliplatin Injection Report Years Considered Figure 13. Global Oxaliplatin Injection Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Oxaliplatin Injection Market Size 2016-2027 (US$ Million) Figure 15. Global Oxaliplatin Injection Sales 2016-2027 (K Units) Figure 16. Global Oxaliplatin Injection Market Size Market Share by Region: 2021 Versus 2027 Figure 17. Global Oxaliplatin Injection Sales Market Share by Region (2016-2021) Figure 18. Global Oxaliplatin Injection Sales Market Share by Region in 2020 Figure 19. Global Oxaliplatin Injection Revenue Market Share by Region (2016-2021) Figure 20. Global Oxaliplatin Injection Revenue Market Share by Region in 2020 Figure 21. Global Oxaliplatin Injection Sales Share by Manufacturer in 2020 Figure 22. The Top 10 and 5 Players Market Share by Oxaliplatin Injection Revenue in 2020 Figure 23. Oxaliplatin Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 24. Global Oxaliplatin Injection Sales Market Share by Type (2016-2021) Figure 25. Global Oxaliplatin Injection Sales Market Share by Type in 2020 Figure 26. Global Oxaliplatin Injection Revenue Market Share by Type (2016-2021) Figure 27. Global Oxaliplatin Injection Revenue Market Share by Type in 2020 Figure 28. Global Oxaliplatin Injection Sales Market Share by Application (2016-2021) Figure 29. Global Oxaliplatin Injection Sales Market Share by Application in 2020 Figure 30. Global Oxaliplatin Injection Revenue Market Share by Application (2016-2021) Figure 31. Global Oxaliplatin Injection Revenue Market Share by Application in 2020 Figure 32. China Oxaliplatin Injection Sales Growth Rate 2016-2027 (K Units) Figure 33. China Oxaliplatin Injection Revenue Growth Rate 2016-2027 (US$ Million) Figure 34. China Oxaliplatin Injection Market Share in Global Market 2016-2027 Figure 35. China 5 and 10 Largest Oxaliplatin Injection Players Market Share by Revenue in Oxaliplatin Injection in 2020 Figure 36. China Oxaliplatin Injection Revenue Share by Type (2016-2021) Figure 37. China Oxaliplatin Injection Revenue Growth Rate by Type in 2016 & 2020 Figure 38. China Oxaliplatin Injection Revenue Share by Application (2016-2021) Figure 39. China Oxaliplatin Injection Revenue Growth Rate by Application in 2016 & 2020 Figure 40. North America Oxaliplatin Injection Sales Growth Rate 2016-2021 (K Units) Figure 41. North America Oxaliplatin Injection Revenue Growth Rate 2016-2021 (US$ Million) Figure 42. North America Oxaliplatin Injection Sales Market Share by Country in 2020 Figure 43. North America Oxaliplatin Injection Revenue Market Share by Country in 2020 Figure 44. United States Oxaliplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 45. United States Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Canada Oxaliplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 47. Canada Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. Europe Oxaliplatin Injection Sales Growth Rate 2016-2021 (K Units) Figure 49. Europe Oxaliplatin Injection Revenue Growth Rate 2016-2021 (US$ Million) Figure 50. Europe Oxaliplatin Injection Sales Market Share by Country in 2020 Figure 51. Europe Oxaliplatin Injection Revenue Market Share by Country in 2020 Figure 52. Germany Oxaliplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 53. Germany Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 54. France Oxaliplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 55. France Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 56. U.K. Oxaliplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 57. U.K. Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 58. Italy Oxaliplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 59. Italy Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 60. Russia Oxaliplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 61. Russia Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 62. Asia Pacific Oxaliplatin Injection Sales Growth Rate 2016-2021 (K Units) Figure 63. Asia Pacific Oxaliplatin Injection Revenue Growth Rate 2016-2021 (US$ Million) Figure 64. Asia Pacific Oxaliplatin Injection Sales Market Share by Region in 2020 Figure 65. Asia Pacific Oxaliplatin Injection Revenue Market Share by Region in 2020 Figure 66. China Oxaliplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 67. China Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 68. Japan Oxaliplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 69. Japan Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 70. South Korea Oxaliplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 71. South Korea Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 72. India Oxaliplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 73. India Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 74. Australia Oxaliplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 75. Australia Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 76. China Taiwan Oxaliplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 77. China Taiwan Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 78. Indonesia Oxaliplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 79. Indonesia Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 80. Thailand Oxaliplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 81. Thailand Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 82. Malaysia Oxaliplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 83. Malaysia Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 84. Latin America Oxaliplatin Injection Sales Growth Rate 2016-2021 (K Units) Figure 85. Latin America Oxaliplatin Injection Revenue Growth Rate 2016-2021 (US$ Million) Figure 86. Latin America Oxaliplatin Injection Sales Market Share by Country in 2020 Figure 87. Latin America Oxaliplatin Injection Revenue Market Share by Country in 2020 Figure 88. Mexico Oxaliplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 89. Mexico Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 90. Brazil Oxaliplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 91. Brazil Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 92. Argentina Oxaliplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 93. Argentina Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 94. Middle East and Africa Oxaliplatin Injection Sales Growth Rate 2016-2021 (K Units) Figure 95. Middle East and Africa Oxaliplatin Injection Revenue Growth Rate 2016-2021 (US$ Million) Figure 96. Middle East and Africa Oxaliplatin Injection Sales Market Share by Country in 2020 Figure 97. Middle East and Africa Oxaliplatin Injection Revenue Market Share by Country in 2020 Figure 98. Turkey Oxaliplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 99. Turkey Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 100. Saudi Arabia Oxaliplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 101. Saudi Arabia Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 102. UAE Oxaliplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 103. UAE Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 104. Oxaliplatin Injection Value Chain Figure 105. Channels of Distribution Figure 106. Distributors Profiles Figure 107. Bottom-up and Top-down Approaches for This Report Figure 108. Data Triangulation Figure 109. Key Executives Interviewed

Sanofi-Aventis Yakult honsha Dr Reddy's laboratories Sun Pharmaceutical Teva Fresenius Kabi Hospira(Pfizer) Mylan Jiangsu Hengrui Medicine Nanjing Pharmaceutical Factory Jiangsu Aosaikang Pharmaceutical Qilu Pharmaceutical Hisun Pharmaceutical Lunan Pharmaceutical Luoxin Halfsky Pharmacy YRPG Hainan Jinrui Pharmaceutical Jari Pharmaceutical Chiatai Tianqing